Clotrimazole
Clotrimazole is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Clotrimazole; Generic name: CLOTRIMAZOLE; Drug class: Azole Antifungal [EPC].
| Brand name | Clotrimazole |
|---|---|
| Generic name | CLOTRIMAZOLE |
| Drug class | Azole Antifungal [EPC] |
| Manufacturer | Hikma Pharmacuticals USA USA Inc. |
| Used for | INDICATIONS AND USAGE Clotrimazole is indicated for the local treatment of oropharyngeal candidiasis. The diagnosis should be confirmed by a KOH smear and/or culture prior to treatment. Clotrimazole is also indicated prophylactically to reduce the incidence of oropharyngeal candidiasis in patients immunocompromised by conditions that include chemotherapy, radiotherapy, or steroid therapy utilized in the treatment of leukemia, solid tumors, or renal transplantation. There are no data from adequate and well-controlled trials to establish the safety and efficacy of this product for prophylactic use in patients immunocompromised by etiologies other than those listed in the previous sentence. (Se |
| Dosage | DOSAGE AND ADMINISTRATION Clotrimazole is administered only as a lozenge that must be slowly dissolved in the mouth. The recommended dose is one troche five times a day for fourteen consecutive days. Only limited data are available on the safety and effectiveness of the clotrimazole troche after prolonged administration; therefore, therapy should be limited to short term use, if possible. For prophylaxis to reduce the incidence of oropharyngeal candidiasis in patients immunocompromised by condit |
| Warnings | WARNING Clotrimazole is not indicated for the treatment of systemic mycoses including systemic candidiasis. |
| Active ingredient(s) | CLOTRIMAZOLE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0bc4b876-ddee-4f03-b44f-544348739a26 |